Showing 2331-2340 of 2839 results for "".
- Signature Facial Experience from Luxury Australian Beauty Brand Now Available in NYChttps://modernaesthetics.com/news/signature-facial-experience-from-luxury-australian-beauty-brand-now-available-in-nyc/2473643/A popular signature facial experience from the Australian luxury beauty brand RATIONALE is now available in New York City. The company launched the RATIONALE Residency at the Equinox Hotel, and private in-home appointments by request, on August 1. Rationale is known for its luxuri
- FDA Issues Warning Over Unapproved Skin Peel Products Sold at Retailershttps://modernaesthetics.com/news/fda-issues-warning-over-unapproved-skin-peel-products-sold-at-retailers/2473642/Several online retailers, including Walmart and Amazon, have received a warning from the US Food and Drug Administration (FDA) for selling unapproved chemical peel skin products. The products are accused of containing corrosive chemicals in high concentrations that are unsafe for use at home with
- Evolus Expands Global Footprint with Introduction of Treatment in Australiahttps://modernaesthetics.com/news/evolus-expands-global-footprint-with-introduction-of-treatment-in-australia/2473641/The performance beauty company, Evolus, has begun operations in Australia with the launch of Nuceiva, a prabotulinumtoxinA. Nuceiva is approved by the Therapeutic Goods Administration (TGA) for the temporary improvement in the appearance of moderate to severe glabella lines in adul
- Dermal Fillers Global Marketing Rising in Demandhttps://modernaesthetics.com/news/dermal-fillers-global-marketing-rising-in-demand/2473640/The dermal fillers global market size is expected to grow from almost $4 billion over the next seven years, reaching an estimated $7.58 billion by 2031. It’s anticipated to register a compound annual growth rate of 8.3% during the forecasted period, according to Premium Market Insights.&nbs
- First, Only US Neurotoxin for Simultaneous Treatment of Upper Facial Lines Gets FDA Approvalhttps://modernaesthetics.com/news/first-only-us-neurotoxin-for-simultaneous-treatment-of-upper-facial-lines-gets-fda-approval/2473638/Merz Aesthetics announced the US Food and Drug Administration approved XEOMIN (incobotulinumtoxinA) as the first and only neurotoxin for the simultaneous treatment of upper facial lines – forehead lines, frown lines, and crow’s feet. XEOMIN was first approved in 2011 f
- Aesthetic Lasers and Energy Devices Market Size to Grow By $2.37Bhttps://modernaesthetics.com/news/aesthetic-lasers-and-energy-devices-market-size-to-grow-by-237b-5/2473637/The global aesthetics laser and energy devices market size is estimated to grow by $2.37 billion from 2024 to 2028. Technavio report the market will grow at a compound annual growth rate of almost 10.87% during the next four years. A key factor driving growth in the market is the
- DefenAge Skincare Launches New Patented Skin Regeneration Technologyhttps://modernaesthetics.com/news/defenage-skincare-launches-new-patented-skin-regeneration-technology/2473630/DefenAge Skincare announced a new skin regeneration technology with the acquisition of a new patent using a regenerative approach for skin care and wound healing. The company says the cutting-edge technology is now available for licensing and product development partnerships, presenting an unpara
- Powered By MRP Gets Series A Investmenthttps://modernaesthetics.com/news/power-by-mrp-gets-series-a-investment/2473629/“Strong tailwinds behind the aesthetics market” was part of the impetus for two prominent growth equity firms to form a strategic partnership with aesthetics device company Powered By MRP, according to a press release. The Series A investment by Aries Capital Partners and Sw
- Study: Patients Prefer Top-to-Bottom Injection Techniquehttps://modernaesthetics.com/news/study-patients-prefer-top-to-bottom-injection-technique/2473627/Orienting the needle from top to bottom, taking into account migration to the upper lip, led to greater patient satisfaction in a study of lip rejuvenation techniques published in Cureus. Dr. Omer Buhsem conducted a randomized retrospective study of 216 female patients, using a top-to-b
- US Leads North America Dermal Fillers Market Share, Asia-Pacific Region Forecasts Highest Growthhttps://modernaesthetics.com/news/us-leads-north-american-dermal-fillers-market-share-asia-pacific-region-shows-highest-growth/2473625/The Global Dermal Fillers Market – Focused Insights 2024-2029 determined the global dermal fillers market is expected to grow at a compound annual growth rate of 8.31% over the next five years. Research found the US dominated the dermal fillers market shar